Cetera Advisor Networks LLC increased its position in Cigna Corp (NYSE:CI) by 33.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 8,479 shares of the health services provider’s stock after buying an additional 2,139 shares during the period. Cetera Advisor Networks LLC’s holdings in Cigna were worth $1,360,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the stock. Mascoma Wealth Management LLC boosted its holdings in shares of Cigna by 8.1% during the 4th quarter. Mascoma Wealth Management LLC now owns 709 shares of the health services provider’s stock valued at $135,000 after purchasing an additional 53 shares during the last quarter. Howe & Rusling Inc. boosted its holdings in shares of Cigna by 1.3% during the 4th quarter. Howe & Rusling Inc. now owns 4,585 shares of the health services provider’s stock valued at $871,000 after purchasing an additional 61 shares during the last quarter. Accurate Investment Solutions Inc. boosted its holdings in shares of Cigna by 9.5% during the 1st quarter. Accurate Investment Solutions Inc. now owns 706 shares of the health services provider’s stock valued at $114,000 after purchasing an additional 61 shares during the last quarter. CX Institutional boosted its holdings in shares of Cigna by 1.9% during the 1st quarter. CX Institutional now owns 3,523 shares of the health services provider’s stock valued at $567,000 after purchasing an additional 66 shares during the last quarter. Finally, First Command Bank boosted its holdings in shares of Cigna by 11.8% during the 4th quarter. First Command Bank now owns 636 shares of the health services provider’s stock valued at $121,000 after purchasing an additional 67 shares during the last quarter. 88.61% of the stock is owned by institutional investors.
Shares of NYSE:CI opened at $155.29 on Thursday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.89. Cigna Corp has a 12 month low of $141.95 and a 12 month high of $226.60. The stock has a market capitalization of $58.93 billion, a P/E ratio of 10.92, a price-to-earnings-growth ratio of 0.78 and a beta of 0.69.
Cigna (NYSE:CI) last announced its quarterly earnings results on Thursday, May 2nd. The health services provider reported $3.90 EPS for the quarter, beating the Zacks’ consensus estimate of $3.74 by $0.16. Cigna had a net margin of 4.11% and a return on equity of 14.23%. The firm had revenue of $33.43 billion during the quarter, compared to the consensus estimate of $32.79 billion. During the same quarter last year, the firm earned $4.11 EPS. The firm’s revenue for the quarter was up 192.9% compared to the same quarter last year. On average, sell-side analysts forecast that Cigna Corp will post 16.54 earnings per share for the current year.
In related news, Director William D. Zollars sold 272 shares of the stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $168.43, for a total value of $45,812.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Brian C. Evanko acquired 2,000 shares of Cigna stock in a transaction that occurred on Monday, March 11th. The stock was purchased at an average cost of $163.40 per share, for a total transaction of $326,800.00. The disclosure for this purchase can be found here. Corporate insiders own 0.80% of the company’s stock.
CI has been the subject of several research reports. ValuEngine downgraded shares of Cigna from a “hold” rating to a “sell” rating in a report on Thursday, February 28th. UBS Group initiated coverage on shares of Cigna in a report on Tuesday, April 23rd. They set a “buy” rating and a $185.00 price objective for the company. Zacks Investment Research downgraded shares of Cigna from a “hold” rating to a “sell” rating in a report on Tuesday, April 9th. Goldman Sachs Group reissued a “buy” rating on shares of Cigna in a report on Saturday, February 2nd. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $245.00 price target on shares of Cigna in a report on Sunday, April 21st. One research analyst has rated the stock with a sell rating, two have given a hold rating and fifteen have given a buy rating to the company. Cigna currently has an average rating of “Buy” and an average price target of $225.85.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Recommended Story: Bond
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.